Molecular characterization of heterogeneous mesenchymal stem cells with single-cell transcriptomes

Biotechnology Advances

Volumn 31, Issue 2, 2013, Pages 312-317

  Li, Zhongjun ^a,b   Zhang, Chao ^c   Weiner, Leslie P ^b   Zhang, Yiqiang ^d   Zhong, Jiang F ^b  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^d UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

Heterogeneity; Mesenchymal stem cells; Single cell transcriptome

Indexed keywords

BIOINFORMATIC ANALYSIS; CELL POPULATIONS; CELL THERAPY; CLINICAL SITUATIONS; DENDROGRAMS; DEVELOPMENTAL POTENTIAL; DEVELOPMENTAL STAGE; EXPRESSION PROFILING; HETEROGENEITY; INDIVIDUAL CELLS; MESENCHYMAL STEM CELL; MOLECULAR CHARACTERIZATION; MOLECULAR INFORMATION; MOLECULAR UNDERSTANDING; MRNA EXPRESSION; REGENERATIVE MEDICINE; SIMILARITY MATRIX; SINGLE CELLS; SMALL MOLECULES; THERAPEUTIC APPLICATION; THERAPEUTIC POTENTIALS; THERAPEUTIC VALUES; TRANSCRIPTOME ANALYSIS; TRANSCRIPTOME PROFILES; TRANSCRIPTOMES;

BIOINFORMATICS; CELL CULTURE; CELL PROLIFERATION; CHARACTERIZATION; GENE EXPRESSION;

CLONE CELLS;

BIOASSAY; BIOINFORMATICS; BIOMARKER; DEVELOPMENTAL STAGE; DISEASE TREATMENT; GENE EXPRESSION; GENETIC ENGINEERING; HETEROGENEITY; MATURATION; MEDICINE; MOLECULAR ANALYSIS;

ANIMAL; GENE EXPRESSION PROFILING; HUMAN; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMA CELL; METHODOLOGY; MICROFLUIDIC ANALYSIS; PHYSIOLOGY; REVIEW; SINGLE CELL ANALYSIS;

ANIMALS; GENE EXPRESSION PROFILING; HUMANS; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; MICROFLUIDIC ANALYTICAL TECHNIQUES; SINGLE-CELL ANALYSIS;

EID: 84873731080     PISSN: 07349750     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biotechadv.2012.12.003     Document Type: Review

References (67)

1. Bao X., Wei J., Feng M., Lu S., Li G., Dou W., et al. Transplantation of human bone marrow-derived mesenchymal stem cells promotes behavioral recovery and endogenous neurogenesis after cerebral ischemia in rats. Brain Res 2011, 1367:103-113.
2. Brecher G., Cronkite E.P. Post-radiation parabiosis and survival in rats. Proc Soc Exp Biol Med 1951, 77:292-294.
3. Buhring H.-J., Battula V.L., Treml S., Schewe B., Kanz L., Vogel W. Novel markers for the prospective isolation of human MSC. Ann N Y Acad Sci 2007, 1106:262-271.
4. Chen Y., Zhong J.F. Microfluidic devices for high-throughput gene expression profiling of single hESC-derived neural stem cells. Methods Mol Biol 2008, 438:293-303.
5. Chen S., Zhang Q., Wu X., Schultz P.G., Ding S. Dedifferentiation of lineage-committed cells by a small molecule. J Am Chem Soc 2004, 126:410-411.
6. Choi M., Kim H., Park J., Lee T., Baik C., Chai Y., et al. Selection of optimal passage of bone marrow-derived mesenchymal stem cells for stem cell therapy in patients with amyotrophic lateral sclerosis. Neurosci Lett 2010, 472:94-98.
7. Choi S.A., Lee J.Y., Wang K.C., Phi J.H., Song S.H., Song J., et al. Human adipose tissue-derived mesenchymal stem cells: characteristics and therapeutic potential as cellular vehicles for prodrug gene therapy against brainstem gliomas. Eur J Cancer 2012, 48:129-137.
8. Danielyan L., Schafer R., von Ameln-Mayerhofer A., Bernhard F., Verleysdonk S., Buadze M., et al. Therapeutic efficacy of intranasally delivered mesenchymal stem cells in a rat model of Parkinson disease. Rejuvenation Res 2011, 14:3-16.
9. Digirolamo C.M., Stokes D., Colter D., Phinney D.G., Class R., Prockop D.J. Propagation and senescence of human marrow stromal cells in culture: a simple colony-forming assay identifies samples with the greatest potential to propagate and differentiate. Br J Haematol 1999, 107:275-281.
10. Ding S., Wu T.Y., Brinker A., Peters E.C., Hur W., Gray N.S., et al. Synthetic small molecules that control stem cell fate. Proc Natl Acad Sci U S A 2003, 100:7632-7637.
11. Dominici M., Le Blanc K., Mueller I., Slaper-Cortenbach I., Marini F., Krause D., et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 2006, 8:315-317.
12. Evsikov A.V., Solter D., Evsikov A.V., Solter D. Comment on " 'Stemness': transcriptional profiling of embryonic and adult stem cells" and "a stem cell molecular signature". Science 2003, 302:393. [author reply].
13. Fan J.-B., Chen J., April C.S., Fisher J.S., Klotzle B., Bibikova M., et al. Highly parallel genome-wide expression analysis of single mammalian cells. PLoS One 2012, 7:e30794.
14. Gnecchi M., Zhang Z., Ni A., Dzau V.J. Paracrine mechanisms in adult stem cell signaling and therapy. Circ Res 2008, 103:1204-1219.
15. Gnecchi M., Danieli P., Cervio E. Mesenchymal stem cell therapy for heart disease. Vascul Pharmacol 2012, 57:48-55.
16. Ivanova N.B., Dimos J.T., Schaniel C., Hackney J.A., Moore K.A., Lemischka I.R., et al. A stem cell molecular signature. Science 2002, 298:601-604.
17. Jia L., Young M.F., Powell J., Yang L., Ho N.C., Hotchkiss R., et al. Gene expression profile of human bone marrow stromal cells: high-throughput expressed sequence tag sequencing analysis. Genomics 2002, 79:7-17.
18. Knight Z.A., Shokat K.M. Chemical genetics: where genetics and pharmacology meet. Cell 2007, 128:425-430.
19. Kuznetsov S.A., Krebsbach P.H., Satomura K., Kerr J., Riminucci M., Benayahu D., et al. Single-colony derived strains of human marrow stromal fibroblasts form bone after transplantation in vivo. J Bone Miner Res 1997, 12:1335-1347.
20. Lee P.H., Park H.J. Bone marrow-derived mesenchymal stem cell therapy as a candidate disease-modifying strategy in Parkinson's disease and multiple system atrophy. J Clin Neurol 2009, 5:1-10.
21. Li W., Wei W., Zhu S., Zhu J., Shi Y., Lin T., et al. Generation of rat and human induced pluripotent stem cells by combining genetic reprogramming and chemical inhibitors. Cell Stem Cell 2009, 4:16-19.
22. Li S.C., Jin Y., Loudon W.G., Song Y., Ma Z., Weiner L.P., et al. Increase developmental plasticity of human keratinocytes with gene suppression. Proc Natl Acad Sci U S A 2011, 108:12793-12798.
23. Li T.-S., Cheng K., Malliaras K., Smith R.R., Zhang Y., Sun B., et al. Direct comparison of different stem cell types and subpopulations reveals superior paracrine potency and myocardial repair efficacy with cardiosphere-derived cells. J Am Coll Cardiol 2012, 59:942-953.
24. Liu J., Wu X., Mitchell B., Kintner C., Ding S., Schultz P.G. A small-molecule agonist of the Wnt signaling pathway. Angew Chem Int Ed Engl 2005, 44:1987-1990.
25. Lukaszewicz A.I., McMillan M.K., Kahn M. Small molecules and stem cells. Potency and lineage commitment: the new quest for the fountain of youth. J Med Chem 2010, 53:3439-3453.
26. Madonna R., De Caterina R. Stem cells and growth factor delivery systems for cardiovascular disease. J Biotechnol 2011, 154:291-297.
27. Matysiak M., Orlowski W., Fortak-Michalska M., Jurewicz A., Selmaj K. Immunoregulatory function of bone marrow mesenchymal stem cells in EAE depends on their differentiation state and secretion of PGE2. J Neuroimmunol 2011, 233:106-111.
28. Mendez-Ferrer S., Michurina T.V., Ferraro F., Mazloom A.R., Macarthur B.D., Lira S.A., et al. Mesenchymal and haematopoietic stem cells form a unique bone marrow niche. Nature 2010, 466:829-834.
29. Morando S., Vigo T., Esposito M., Casazza S., Novi G., Principato M.C., et al. The therapeutic effect of mesenchymal stem cell transplantation in experimental autoimmune encephalomyelitis is mediated by peripheral and central mechanisms. Stem Cell Res Ther 2012, 3:3.
30. Morikawa S., Mabuchi Y., Kubota Y., Nagai Y., Niibe K., Hiratsu E., et al. Prospective identification, isolation, and systemic transplantation of multipotent mesenchymal stem cells in murine bone marrow. J Exp Med 2009, 206:2483-2496.
31. Muraglia A., Cancedda R., Quarto R. Clonal mesenchymal progenitors from human bone marrow differentiate in vitro according to a hierarchical model. J Cell Sci 2000, 113:1161-1166.
32. Nakajima H., Uchida K., Guerrero A.R., Watanabe S., Sugita D., Takeura N., et al. Transplantation of mesenchymal stem cells promotes an alternative pathway of macrophage activation and functional recovery after spinal cord injury. J Neurotrauma 2012, 29:1614-1625.
33. Ohnishi S., Yanagawa B., Tanaka K., Miyahara Y., Obata H., Kataoka M., et al. Transplantation of mesenchymal stem cells attenuates myocardial injury and dysfunction in a rat model of acute myocarditis. J Mol Cell Cardiol 2007, 42:88-97.
34. Panepucci R.A., Siufi J.L.C., Silva W.A., Proto-Siquiera R., Neder L., Orellana M., et al. Comparison of gene expression of umbilical cord vein and bone marrow-derived mesenchymal stem cells. Stem Cells 2004, 22:1263-1278.
35. Park J.H., Kim D.Y., Sung I.Y., Choi G.H., Jeon M.H., Kim K.K., et al. Long-term results of spinal cord injury therapy using mesenchymal stem cells derived from bone marrow in humans. Neurosurgery 2012, 70:1238-1247. [discussion 47].
36. Park S.-S., Lee Y.J., Lee S.H., Lee D., Choi K., Kim W.-H., et al. Functional recovery after spinal cord injury in dogs treated with a combination of Matrigel and neural-induced adipose-derived mesenchymal stem cells. Cytotherapy 2012, 14:584-597.
37. Psaltis P.J., Zannettino A.C., Worthley S.G., Gronthos S. Concise review: mesenchymal stromal cells: potential for cardiovascular repair. Stem Cells 2008, 26:2201-2210.
38. Qian H., Le Blanc K., Sigvardsson M. Primary mesenchymal stem and progenitor cells from bone marrow lack expression of CD44 protein. J Biol Chem 2012, 287:25795-25807.
39. Ramalho-Santos M., Yoon S., Matsuzaki Y., Mulligan R.C., Melton D.A., Ramalho-Santos M., et al. "Stemness": transcriptional profiling of embryonic and adult stem cells. Science 2002, 298:597-600.
40. Rodriguez A.M., Elabd C., Amri E.-Z., Ailhaud G., Dani C. The human adipose tissue is a source of multipotent stem cells. Biochimie 2005, 87:125-128.
41. Russell K.C., Phinney D.G., Lacey M.R., Barrilleaux B.L., Meyertholen K.E., O'Connor K.C. In vitro high-capacity assay to quantify the clonal heterogeneity in trilineage potential of mesenchymal stem cells reveals a complex hierarchy of lineage commitment. Stem Cells 2011, 28:788-798.
42. Satija N.K., Gurudutta G.U., Sharma S., Afrin F., Gupta P., Verma Y.K., et al. Mesenchymal stem cells: molecular targets for tissue engineering. Stem Cells Dev 2007, 16:7-23.
43. Sheikh A.M., Nagai A., Wakabayashi K., Narantuya D., Kobayashi S., Yamaguchi S., et al. Mesenchymal stem cell transplantation modulates neuroinflammation in focal cerebral ischemia: contribution of fractalkine and IL-5. Neurobiol Dis 2011, 41:717-724.
44. Shi Y., Do J.T., Desponts C., Hahm H.S., Scholer H.R., Ding S. A combined chemical and genetic approach for the generation of induced pluripotent stem cells. Cell Stem Cell 2008, 2:525-528.
45. Silva W.A., Covas D.T., Panepucci R.A., Proto-Siqueira R., Siufi J.L.C., Zanette D.L., et al. The profile of gene expression of human marrow mesenchymal stem cells. Stem Cells 2003, 21:661-669.
46. Song H., Chang W., Song B.W., Hwang K.C. Specific differentiation of mesenchymal stem cells by small molecules. Am J Stem Cell 2012, 1:22-30.
47. Specht K.M., Shokat K.M. The emerging power of chemical genetics. Curr Opin Cell Biol 2002, 14:155-159.
48. Takahashi K., Tanabe K., Ohnuki M., Narita M., Ichisaka T., Tomoda K., et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 2007, 131:861-872.
49. Toghraie F.S., Chenari N., Gholipour M.A., Faghih Z., Torabinejad S., Dehghani S., et al. Treatment of osteoarthritis with infrapatellar fat pad derived mesenchymal stem cells in rabbit. Knee 2011, 18:71-75.
50. Tormin A., Li O., Brune J.C., Walsh S., Schutz B., Ehinger M., et al. CD146 expression on primary nonhematopoietic bone marrow stem cells is correlated with in situ localization. Blood 2011, 117:5067-5077.
51. Tremain N., Korkko J., Ibberson D., Kopen G.C., DiGirolamo C., Phinney D.G. MicroSAGE analysis of 2,353 expressed genes in a single cell-derived colony of undifferentiated human mesenchymal stem cells reveals mRNAs of multiple cell lineages. Stem Cells 2001, 19:408-418.
52. Uccelli A., Moretta L., Pistoia V. Mesenchymal stem cells in health and disease. Nat Rev Immunol 2008, 8:726-736.
53. Uemura E. Age-related changes in neuronal RNA content in rhesus monkeys (Macaca mulatta). Brain Res Bull 1980, 5:117-119.
54. Wagner W., Wein F., Seckinger A., Frankhauser M., Wirkner U., Krause U., et al. Comparative characteristics of mesenchymal stem cells from human bone marrow, adipose tissue, and umbilical cord blood. Exp Hematol 2005, 33:1402-1416.
55. Wagner W., Feldmann R.E., Seckinger A., Maurer M.H., Wein F., Blake J., et al. The heterogeneity of human mesenchymal stem cell preparations-evidence from simultaneous analysis of proteomes and transcriptomes. Exp Hematol 2006, 34:536-548.
56. Wernig M., Lengner C.J., Hanna J., Lodato M.A., Steine E., Foreman R., et al. A drug-inducible transgenic system for direct reprogramming of multiple somatic cell types. Nat Biotechnol 2008, 26:916-924.
57. Wislet-Gendebien S., Laudet E., Neirinckx V., Alix P., Leprince P., Glejzer A., et al. Mesenchymal stem cells and neural crest stem cells from adult bone marrow: characterization of their surprising similarities and differences. Cell Mol Life Sci 2012, 69:2593-2608.
58. Wislet-Gendebien S., Poulet C., Neirinckx V., Hennuy B., Swingland J.T., Laudet E., et al. In vivo tumorigenesis was observed after injection of in vitro expanded neural crest stem cells isolated from adult bone marrow. PLoS One 2012, 7:e46425. [Electronic Resource].
59. Wu X., Ding S., Ding Q., Gray N.S., Schultz P.G. A small molecule with osteogenesis-inducing activity in multipotent mesenchymal progenitor cells. J Am Chem Soc 2002, 124:14520-14521.
60. Wu X., Walker J., Zhang J., Ding S., Schultz P.G. Purmorphamine induces osteogenesis by activation of the hedgehog signaling pathway. Chem Biol 2004, 11:1229-1238.
61. Xu Y., Shi Y., Ding S. A chemical approach to stem-cell biology and regenerative medicine. Nature 2008, 453:338-344.
62. Yu J., Vodyanik M.A., Smuga-Otto K., Antosiewicz-Bourget J., Frane J.L., Tian S., et al. Induced pluripotent stem cell lines derived from human somatic cells. Science 2007, 318:1917-1920.
63. Zhang Q., Major M.B., Takanashi S., Camp N.D., Nishiya N., Peters E.C., et al. Small-molecule synergist of the Wnt/beta-catenin signaling pathway. Proc Natl Acad Sci U S A 2007, 104:7444-7448.
64. Zhang M.J., Sun J.J., Qian L., Liu Z., Zhang Z., Cao W., et al. Human umbilical mesenchymal stem cells enhance the expression of neurotrophic factors and protect ataxic mice. Brain Res 2011, 1402:122-131.
65. Zhong J.F., Chen Y., Marcus J.S., Scherer A., Quake S.R., Taylor C.R., et al. A microfluidic processor for gene expression profiling of single human embryonic stem cells. Lab Chip 2008, 8:68-74.
66. Zhong J.F., Feng Y., Taylor C.R. Microfluidic devices for investigating stem cell gene regulation via single-cell analysis. Curr Med Chem 2008, 15:2897-2900.
67. Zhu S., Lu Y., Zhu J., Xu J., Huang H., Zhu M., et al. Effects of intrahepatic bone-derived mesenchymal stem cells autotransplantation on the diabetic beagle dogs. J Surg Res 2011, 168:213-223.